Proton Therapy Indications Techniques and Outcomes Steven J Frank Download 2024 Full Chapter
Proton Therapy Indications Techniques and Outcomes Steven J Frank Download 2024 Full Chapter
Proton Therapy Indications Techniques and Outcomes Steven J Frank Download 2024 Full Chapter
Expert Consult eBooks give you the power to browse and find content,
view enhanced images, share notes and highlights—both online and offline.
Use of the current edition of the electronic version of this book (eBook) is subject to the terms of the nontransferable, limited license
granted on expertconsult.inkling.com. Access to the eBook is limited to the first individual who redeems the PIN, located on the inside
cover of this book, at expertconsult.inkling.com and may not be transferred to another party by resale, lending, or other means.
2015v1.0
Proton Therapy
F I R S T E D I T I O N
Proton Therapy
Indications, Techniques,
and Outcomes
STEVEN J. FRANK, MD
Professor
Radiation Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or
mechanical, including photocopying, recording, or any information storage and retrieval system, without
permission in writing from the publisher. Details on how to seek permission, further information about
the Publisher’s permissions policies and our arrangements with organizations such as the Copyright
Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/
permissions.
This book and the individual contributions contained in it are protected under copyright by the Publisher
(other than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and experience
broaden our understanding, changes in research methods, professional practices, or medical treatment
may become necessary. Practitioners and researchers must always rely on their own experience and
knowledge in evaluating and using any information, methods, compounds or experiments described
herein. Because of rapid advances in the medical sciences, in particular, independent verification
of diagnoses and drug dosages should be made. To the fullest extent of the law, no responsibility is
assumed by Elsevier, authors, editors or contributors for any injury and/or damage to persons or
property as a matter of products liability, negligence or otherwise, or from any use or operation of
any methods, products, instructions, or ideas contained in the material herein.
v
LIST OF CONTRIBUTORS
vi
LIST OF CONTRIBUTORS vii
Proton therapy has been used to treat cancer patients since the early 1950s; however, technologic
advancements in proton therapy delivery with spot scanning and treatment planning systems
are rapidly evolving, making it more accessible for the management of solid tumors. In this first
edition of Proton Therapy: Indications, Techniques, and Outcomes, we aim to communicate the most
up-to-date advancements in radiobiology, indications, literature, management approaches, treat-
ment planning, quality assurance, and outcomes after proton therapy by disease site. Education
and training in proton therapy are more important now than ever before, as systems become
smaller and more cost-effective, resulting in greater access for community hospitals and their
multidisciplinary oncology teams.
The radiobiology of proton therapy and its relative biological effectiveness versus conventional
x-rays (RBE) will continue to be a dynamic field of interest based on the DNA damage and repair
mechanisms in individual tumor cell lines as well as the acute and late effects on normal tissues.
Specifically, multifield optimization intensity-modulated proton therapy (MFO-IMPT) provides
a great opportunity for understanding how best to exploit the linear energy transfer (LET) of
protons at the distal edge of the Bragg peak to our advantage.
Proton therapy quality assurance and management of uncertainties during treatment planning
and treatment delivery will continue to be a hallmark of medical physics. Robust planning,
robust analysis, and robust optimization are important tools during the proton therapy treatment
planning process. Deeper understanding of the variations of stopping power and their effects on
adaptive real-time planning is an exciting opportunity to further advance patient care.
Clinical outcomes by disease site are carefully examined in each clinical chapter, and a special
section on head and neck cases is included that photographically documents the full cycle of
proton therapy care. Finally, the current indications for proton therapy at The University of Texas
MD Anderson Cancer Center are a clarified, as well as opportunities for the advancement of
proton therapy in future indications.
We thank all of the authors and dedicate this first edition of Proton Therapy: Indications,
Techniques, and Outcomes to the late James D. Cox, MD, whose leadership and vision became
a clinical reality in 2006 when the first cancer patient was treated with proton therapy at The
University of Texas MD Anderson Cancer Center.
viii
ACKNOWLEDGMENT
ix
TA B L E O F C O N T E N T S
SECTIO N I Introduction
1. Principles of Radiobiology 2
Li Wang Steven J. Frank
x
TABLE OF CONTENTS xi
21. Appendix 2: Head and Neck Clinical Case Scenarios and Outcomes
by Disease Site See Expert Consult ebook
Houda Bahig G. Brandon Gunn Steven J. Frank
S E C T I O N I
Introduction
1
Principles of Radiobiology
Li Wang ■ Steven J. Frank
Introduction
Radiotherapy is used as one of the major treatment modalities for patients with malignant dis
eases at different disease stages. Currently, the most common radiation choice for the majority of
cancers is photon (x-ray)-based intensity-modulated external beam radiotherapy. Notably, recent
advances in technology and basic and clinical research have facilitated the safe delivery of more
effective and noninvasive radiotherapy for malignant diseases using charged particles, including
intensity-modulated proton therapy. Proton beams deliver most of their energy at the distal edge
of their range (the Bragg peak), which leads to an increase of th - radiation doses to the clinical
targets and minimization of the irradiation dose to adjacent nmmal tissues. Moreover, photon
beams are categorized as low linear energy transfer (LET), whereas proton beams, especially in
the spread-out Bragg peak (SOBP), which majorly contains pragg peaks, are categorized as high
LET Thus in addition to the physical dose distribution adv.antage, proton therapy also presents
distinct biology advantages compared with photon radiation. Even though the biological features
of tumors and normal tissues after photon radiation have 0(:en e,xtensively studied, the biological
responses of tumors and normal tissues to proton radiation are far from clear. The biological
properties of proton beams that differ significantly from those of photons will be summarized in
this chapter. Particular emphasis is placed on relatiye biological effectiveness (REE), DNA
damage, and repair effects induced by protons, proton beam-induced cell death mechanisms,
the impact of proton beams on tumor imm�responses, and the influence of proton beams on
tumor angiogenesis.
2
1—PRINCIPLES OF RADIOBIOLOGY 3
proton beams plays a major role and causes a large proportion of DNA damage compared with
the direct effect of proton beams. 1,7–9 However, Monte Carlo simulations have indicated that the
average number of DNA damages per cluster tends to increase with the increasing of the radia-
tion beam LET, which implies a higher level of DNA damage complexity induced by proton
beams versus by that caused by photon beams. 1,4 These mathematical model prediction results
have been verified by several other studies by testing DNA plasmids or cell lines. Using DNA
plasmids pBR322 or T7 as testing material, the direct damage effect of proton beams to DNA
was proven to generate more DSB clusters compared with non-DSB clusters compared with
photon beams. 7,10 Similar observations were also demonstrated in cell-based studies. An in-
creased complexity of DNA damages and slower DNA damage repair kinetics were observed in
the human skin fibroblast AG01522 cells at the distal end of the SOBP after proton radiation.11
Other than this, large foci, which represent the DSB clusters, were also found more commonly
in Chinese hamster ovary (CHO) cell lines CHO10B2 and irs-20 after proton radiation com-
pared with photon radiation.12 The more severe DNA damage caused by proton beams were also
proven by another study on the thyroid-stimulating hormone–dependent Fischer rat thyroid
cells.13 The authors found more free-end DNAs 1 hour after proton radiation than photon ra-
diation, which means a more rapid DNA damage repair in the cells exposed to photon beams
than those exposed to proton beams. They further verified their results by finding a higher rate
of micronucleus formation and the presence of larger micronuclei in cells treated by proton beams
than those cells treated with photon beams.13 Persistent DNA damage was also observed in dif-
ferent head and neck cancer cell lines after exposure to proton beams versus exposure to photon
beams.14 However, conflicting results were observed in a study using the DNA plasmid pBR322.
In this study, the authors did not find a difference in the amount of the clustered DNA damage
induced by proton beams compared with photon beams in either the liquid or in the dry samples.4
DSB
ATM/ATR
rH2AX
RNF8
MDC1
RNF168
BRCA1 53BP1
CtIP RIF1
Ku 70–80
RAD51 DNA-PKcs
Fig. 1.1 Double-strand break (DSB) repair
pathways ATM, Ataxia-Telangiesctasia mu-
tated; ATR, ataxia telangiectasia and Rad3 re-
lated; HR, homologous recombination; NHEJ,
HR NHEJ nonhomologous end joining.
profound radio response was observed after cells were exposed to photon versus proton beams. On
the other hand, depleting RAD51 led to an enhanced response of A549 cells to proton beams. The
authors claimed a preference of HR versus NHEJ in proton beam–induced DSB repair.19 On the
contrary, conflicting results were reported by others.12 In one study, the authors compared the DSB
repair of the DNA-PKcs wild-type CHO cell line CHO10B2 with its derived radiosensitive
mutant cell line, the DNA-PKcs-deficient cell line irs-20 after cells were exposed to photon and
proton beams.12 Irs-20 cells presented more persistent DSBs compared with CHO10B cells after
cells were exposed to both photon and proton beams. A dependence on the DNA-PKcs in repair-
ing DSBs caused by both proton and photon beams was verified.12 In another study involving the
DNA-PKcs wild-type CHO cell line CHO10B2, Ku80-mutated CHO mutant cell XRS-5,
DNA-PKcs null V3 cells, Rad51D-mutated 51D1 cells, and 14 cell lines derived from V3 cells
with complementary human DNA PKcs containing amino acid substitutions at specific positions,
the cell responses to proton beams versus photon beams were not correlated with the status of
DNA-PKcs or RAD51; thus, no preferential DSB repair pathway of HR or NHEJ was observed
in proton beam–induced DSB repair.18 Other than the previously mentioned, a study using cervi-
cal cancer HeLa cells claimed that the higher cell response rate of proton beams versus photon
beams in the SOBP is in an Artemis protein–dependent manner. Because Artemis protein is a
member of the NHEJ pathway, this result reflects the dependency of the repair of proton beam–
induced DSBs on NHEJ.20 Some other studies also demonstrated the preference of the NHEJ
pathway in the repair of DSBs induced by proton beams.21,22 This evidence includes the activation
of Ataxia-Telangiesctasia mutated (ATM, contributing to NHEJ23) and DNA-PKcs but not
ataxia telangiectasia and Rad3 related (ATR) by proton beams in human lung adenocarcinoma
A549 cells21 and the induction of ATM by proton beams in human prostate cancer PC3 cells.22
1—PRINCIPLES OF RADIOBIOLOGY 5
Taken together, the overall DNA damage caused by proton is different than that of photon
beams, at least to a certain extent. However, the repair mechanisms of the DSBs induced by
proton beams are still unclear. Future studies specifically investigating the DNA repair pathways
of proton beams will translate the findings into biology-based rationales of treatment selection
between proton- and photon-based radiation and the combination of therapies that targeted
specific signal pathways.
Cell Death
One of the severe consequences of the failure of DNA damage repair induced by radiation is cell
death. The mechanisms of photon radiation–induced cell death are intensively studied. Photon
radiation is known to kill cancer cells via apoptosis, necrosis, autophagy, mitotic catastrophe,
and senescence.24–28 However, the mechanisms by which proton radiation induces cell death are
unclear.
CELL SENESCENCE
With emerging evidence, cellular senescence is increasingly being recognized as one of the most
important mechanisms in photon radiation–induced tumor suppression.26,29,30 Similar to that
observed in photon radiation, we found that senescence was also a major type of cell death
induced by a 4-Gy dose of proton beam radiation in HPV-related and HPV-unrelated human
head and neck squamous carcinoma cells at 4 and 6 days after exposure (Fig. 1.3). More impor-
tantly, compared with photon beams, proton beams led to a higher proportion of cells undergoing
senescence in these cell lines. Based on the above facts, the role of combination treatment that
interferes with cell senescence pathways may influence cell responses to proton beams versus
photon beams differently and warrants further investigation.
CELL APOPTOSIS
Apoptosis plays a modest role in the response of many solid tumors to photon irradiation. To
date, little is known about cell apoptosis after they are exposed to proton radiation. The study
result from one group31 indicated that compared with photon beams, proton beams led to a
greater level of cell apoptosis at 48 hours after radiation in H460 and A549.21,31 Similarly, a study
(16 in DNA damage literature) using patient-derived glioma stem cells to compare proton beam
with photon beam irradiation indicated that proton beams induce more cell apoptosis and lead
to more cell apoptosis–related caspase-3 activation and poly(adenosine diphosphate [ADP]-
ribose) polymerase (PARP) cleavage. Other than the higher incidence of cell apoptosis after
6 PROTON THERAPY
DAPI
γ-Tubulin
Merge
A B
SqCC/Y1
100 Control 100 HN5
P all < .001
XRT
Percentage of mitotic
80 80 *P < .05
catastrophe cells
PRT *
* *
60 60 *
* * *
40 40 * * *
20 20
0 0
4h 24 h 48 h 72 h 4h 24 h 48 h 72 h
DAPI
γ-Tubulin
Merge
C D
100 100
UPCI-SCC-154 UMSCC-47
Percentage of mitotic
* *
* * * *
60 60 *
* *
40 40 * *
20 20
0 0
4h 24 h 48 h 72 h 4h 24 h 48 h 72 h
Time after 4 Gy irradiation (hours)
Fig. 1.2 Mitotic catastrophe in head and neck squamous cell carcinoma cell lines after exposure to photon
(XRT) versus proton (PRT) irradiation. Two human papillomavirus (HPV)–negative cell lines (SqCC/Y1, panel
A; and HN5, panel B) and two HPV-positive cell lines (UPCI-SCC-154, panel C; UMSCC-47, panel D) were
tested. Cells were fixed, permeabilized, blocked, and incubated with anti-g-tubulin (primary antibody) and
Texas Red (secondary antibody) to visualize immunoreactivity; DNA was stained with 4’,6-diamidino-2-
phenylindole. Immunoreactions were visualized with a Leica Microsystem at 3100 magnification.
1—PRINCIPLES OF RADIOBIOLOGY 7
Control
XRT
PRT
A
50 SqCC/Y1 50 HN5
Control P all < .001 P all < .001
40 XRT 40
PRT
30 30
20 20
Percentage of senescent cells
10 10
0 0
4 days 6 days 4 days 6 days
50 UPCI-SCC-154 50 UMSCC-47
30 30
20 20
10 10
0 0
4 days 6 days 4 days 6 days
Time after 4 Gy irradiation (days)
Fig. 1.3 Senescence in head and neck squamous cell carcinoma cell lines after exposure to photon (XRT)
versus proton (PRT) irradiation. Two human papillomavirus (HPV)–negative cell lines (SqCC/Y1 and HN5) and
two HPV-positive cell lines (UPCI-SCC-154 and UMSCC-47) were stained with senescence-associated
b-galactosidase (SA-b-gal) and analyzed 4 days and 6 days later. (A) Photographs of senescent cells at
6 days after irradiation. Cells were photographed with an optic microscope at 320 magnification. Cells stain-
ing positive for SA-b-gal show blue cytoplasmic staining.
8 PROTON THERAPY
proton beam versus photon beam radiation, studies from other groups also revealed the time
point differences of the cell apoptosis occurrence between photon versus proton beam radiation.
One group from Italy32 exposed the prostate adenocarcinoma cell line PC3 to photon and proton
beams. They found that the peak of PC3 cells undergoing apoptosis was reached at 8 hours after
proton irradiation compared with 48 hours for photon irradiation. Differently, a study from
Germany on HeLa cells indicated that during the maximum observation time of 48 hours, the
proportion of apoptotic cells induced by proton beams increased with time.33 Other than the
above direct evidence of cell apoptosis induced by proton beams, indirect evidence of cell
apoptosis–related signal pathway changes were also generated. One study21 demonstrated sig-
nificantly more upregulation of proapoptotic gene, Bax, and downregulation of antiapoptotic
gene, Bcl-2, at 12 hours after lung cancer A549 cells were exposed to proton beams compared
with those cells exposed to photon beams. However, our study in HPV-related and HPV-
unrelated human head and neck squamous carcinoma cells showed a different result (Fig. 1.4A).
Both photon and proton beams only induced limited cell apoptosis, and no difference was ob-
served in the proportion of proton beam–induced cell apoptosis versus that induced by photon
beams. Because both proton beams and photon beams can cause DNA damage and DNA dam-
age is a major pathway by which radiation causes apoptosis, strategies to target apoptosis pathway
to enhance proton beam or photon beam–induced tumor cell apoptosis may be another effective
strategy for enhancing the antitumor activity of radiation.
CELL NECROSIS
Necrosis typically occurs after a large dose of photon radiation,27,34 but it has also been observed
in cancer cell lines and patient tumor tissue–derived cancer cells after a single 4-Gy or 6-Gy
dose of photon irradiation.35 Comparing the proportion of cells undergoing necrosis in four
HPV-related and HPV-unrelated human head and neck squamous carcinoma cell lines after a
single 4-Gy dose of proton or photon beam radiation, we found that proton and photon beams
only led to significantly increased necrosis in one HPV-unrelated cell line 48 hours after radia-
tion, and no differences were found between proton versus photon beams (Fig. 1.4B). Mecha-
nistic studies of tumor necrosis have identified several molecular targets that mediate necrosis
after treatment.34–36 Interfering with those molecular targets may be another new approach to
promote both proton and photon beam–induced necrotic cell death and may be a potential to
enhance radiosensitivity.34,35
In summary, mitotic catastrophe and senescence are the major types of cell death induced by
both photon and proton beams, and proton beams kill more cells by either mechanism than
photon beams. Individual cancer patients with different gene mutation statuses may derive dif-
ferent levels of benefit from targeted therapy that interferes with different cell death–related
pathways according to whether the radiotherapy is photon or proton based. Further mechanistic
and in vivo studies may open a new avenue of improving tumor control with proton or photon
radiation and lead to novel, individually optimized combination treatment plans consisting of
molecular-targeted therapy combined with proton or photon beams for cancer patients with
tumors of different biological features.
12 SqCC/Y1 12 HN5
10 Control 10
XRT P all > .05
8 PRT 8
6 P < .05 6
Percentage of apoptotic cells
4 4
2 2
0 0
4h 24 h 48 h 4h 24 h 48 h
12 UPCI-SCC-154 12 UMSCC-47
10 10
P all > .05 P all > .05
8 8
6 6
4 4
2 2
0 0
4h 24 h 48 h 4h 24 h 48 h
A Time after 4 Gy irradiation (hours)
60 SqCC/Y1 60 HN5
P < .001
50 Control 50
XRT P < .05
P all > .05
40 PRT 40
30 30
20 20
Percentage of necrotic cells
10 10
0 0
4h 24 h 48 h 4h 24 h 48 h
60 UPCI-SCC-154 60 UMSCC-47
50 50
P all > .05 P all > .05
40 40
30 30
20 20
10 10
0 0
4h 24 h 48 h 4h 24 h 48 h
B Time after 4 Gy irradiation (hours)
Fig. 1.4 Necrosis and apoptosis in head and neck squamous cell carcinoma cell lines after photon (XRT) or
proton (PRT) irradiation. Two human papillomavirus (HPV)–negative cell lines (SqCC/Y1 and HN5) and two HPV-
positive cell lines (UPCI-SCC-154 and UMSCC-47) were subjected to terminal deoxy-nucleotidyltransferase
(TdT) dYTP nick-end labeling (TUNEL) and incubated with fluorescein isothiocyanate (FITC)-conjugated
annexin V and propidium iodide and analyzed by BD Accuri C6. Percentages of necrotic or apoptotic
cells were quantified with FlowJo V10 software. (A) Quantification of apoptotic cells. (B) Quantification of
necrotic cells.
10 PROTON THERAPY
Fig. 1.5 Immune response changes after x-ray-based radiation. ATP, Adenosine triphosphate; DAMP,
damage-associated molecular pattern; HMGB1, high mobility group box-1; IL, interleukin; PD-L1, pro-
grammed death-ligand 1. (Summarized based on Diegeler S, Hellweg CE. Intercellular communication of
tumor cells and immune cells after exposure to different ionizing radiation qualities. Front Immunol.
2017;8:664 and Ebner DK, Tinganelli W, Helm A, et al. The immunoregulatory potential of particle radiation
in cancer therapy. Front Immunol. 2017;8:99.)
beams can be translated into demonstrable clinical benefits of normal tissue protection and tumor
control for these cancers remains unclear.
Currently, clinical use of proton beams is based largely on the experiences that are derived from
photon beam radiation. However, the difference in the energy deposition patterns of photon beams
and proton beams means that equal doses of proton or photon beam radiation do not produce equal
biological effects; one type of radiation may be more effective at killing cells than the other one. The
RBE of proton beams is defined as the ratio of the doses required for photon versus proton beams
radiation to produce the same level of biological effectiveness, such as cell killing or DNA dam-
age.50,51 The RBE of proton beams has been recognized as variable values. The RBE is determined
by a number of physical and biological factors, such as proton beam energy, depth, radiation dose,
radiation fraction size, radiation fraction number, cell or tissue types, and the end points.47,52–57 The
advantages of proton versus photon beams only can be presented in the case of accurately assured
higher/equal target volume dose and lowered surrounding normal tissue dose in proton radiation.
Therefore an accurate proton beam RBE is required in proton beam radiation.
In current clinical practice, the RBE of proton therapy has been assumed to be 1.1 regard-
less of tumor type, beam energy, and treatment planning differences.49 This RBE value was
mainly derived from preclinical experiments with normal cells or early-reacting normal tissues
rather than cancer cells or tumor xenografts.53–55 Moreover, these experiments also demon-
strated a big range of RBE at the middle of SOBP (ranging from 0.9 to 2.1 for in vitro ex-
periments and from 0.7 to 1.6 for in vivo experiments).52 Thus, use of this constant RBE
without considering differences in tumor biology or the effects of fractionation increases the
1—PRINCIPLES OF RADIOBIOLOGY 11
extent of clinical dose uncertainties for tumor and normal tissues associated with proton
therapy, the nature and extent of which are largely unknown but are crucial to the safe and
effective use of proton therapy.
More importantly, emerging evidence has established the increased RBE values in regions of
high LET at the distal falloff of most proton beams, which are normally located within the target
volume.58–60 Thus, special attention should bring in treatment planning of proton beam radiation
to avoid locating organs at risk to the distal portion of SOBP, which might induce normal tissue
complications at the distal field edges. Furthermore, because in vivo study also found a trend that
late-responding tissues may have higher RBE values compared with early-responding tissues,61
more attention should be placed on the observation of late normal tissue response in those
patients who accepted proton beam radiation in the clinical setting.
In summary, because of the uncertainties of the RBE in proton beam radiation, more studies
on the clinically relevant dose range in the response of different normal tissues or tumor types in
animals are needed.
Immune Response
Accumulated evidence has demonstrated that photon beam radiation not only can control tumor
by local tumor irradiation but can also influence tumor growth by the effects of photon radiation
on the activation and suppression of the immune system (Fig. 1.5).62–64 To avoid the immunosup-
pression effect and to enhance the immunoactivation effect of photon radiation, the impact of
photon radiation on the immune system is under extensive study currently to investigate the pos-
sibility of radiation and immune therapy combination to improve cancer treatment outcomes.
FOOTNOTES:
[99] The slope of the mountain near Kíev, where to-day is the
suburb of Podól.
[100] Pagan divinities. For Troyán, see note on p. 82; Khors,
the god of the sun (cf. note on p. 93); Velés, the god of
abundance (cf. note on p. 83); Perún, the god of thunder (see p.
70).
Daniel the Prisoner. (XIII. century.)
For some unknown reason Daniel had been imprisoned in
an island in the Lake of Lach, in the Government of Olónetsk.
He seems to have belonged to the druzhína of Yarosláv
Vsévolodovich of Pereyáslavl, who died in 1247 as Grand
Prince of Vladímir. That is all that is known about the life of
this layman, one of the few in the old period whose writing
has come down to our times. The begging letter which he
addressed to the Prince is composed of incorrectly quoted
biblical passages and popular saws and proverbs; many of
these he drew from an ancient collection, The Bee, in which
moral subjects are arranged in chapters. In their turn, Daniel’s
saws have largely entered into the composition of a very
popular collection of the same kind, The Emerald.
A SERMON ON OMENS
THE ZADÓNSHCHINA
Let us go, O brothers, into the midnight country, the lot of Japheth,
[102] the son of Noah, from whom has risen the most glorious Russia;
let us there ascend the Kíev mountains, and look by the smooth
Dnieper over the whole Russian land, and hence to the Eastern land,
the lot of Shem, the son of Noah, from whom were born the Chinese,
[103] the pagan Tartars, the Mussulmans. They had defeated the race
of Japheth on the river Kayála.[104] And ever since, the Russian land
has been unhappy, and from the battle of the Kálka[105] up to
Mamáy’s defeat it has been covered with grief and sorrow, weeping
and lamenting its children. The Prince and the boyárs, and all the
brave men who had left all their homes, and wealth, and wives,
children, and cattle, having received honour and glory of this world,
have laid down their heads for the Russian land and the Christian
faith.
Let us come together, brothers and friends, sons of Russia! Let us
join word to word! Let us make the Russian land merry, and cast
sorrow on the eastern regions that are to the lot of Shem! Let us sing
about the victory over the heathen Mamáy, and an eulogy to the
Grand Prince Dmítri Ivánovich and his brother,[106] Prince Vladímir
Andréevich!... We shall sing as things have happened, and will not
race in thought, but will mention the times of the first years; we will
praise the wise Boyán,[107] the famous musician in Kíev town. That
wise Boyán put his golden fingers on the living strings, sang the
glory of the Russian princes, to the first Prince Rúrik, Ígor Rúrikovich
and Svyatosláv, Yaropólk, Vladímir Svyatoslávich, Yarosláv
Vladímirovich, praising them with songs and melodious musical
words.—But I shall mention Sofóniya of Ryazán, and shall praise in
songs and musical words the Prince Dmítri Ivánovich and his
brother, Prince Vladímir Andréevich, for their bravery and zeal was
for the Russian land and the Christian faith. For this, Grand Prince
Dmítri Ivánovich and his brother, Prince Vladímir Andréevich,
sharpened their hearts in bravery, arose in their strength, and
remembered their ancestor, Prince Vladímir of Kíev, the tsar of
Russia.
O lark, joy of beautiful days! Fly to the blue clouds, look towards
the strong city of Moscow, sing the glory of Grand Prince Dmítri
Andréevich! They have risen like falcons from the Russian land
against the fields of the Pólovtses. The horses neigh at the Moskvá;
the drums are beaten at the Kolómna; the trumpets blare at
Serpukhóv; the glory resounds over the whole Russian land.
Wonderfully the standards stand at the great Don; the embroidered
flags flutter in the wind; the gilded coats of mail glisten. The bells are
tolled in the vyéche[108] of Nóvgorod the Great. The men of
Nóvgorod stand in front of St. Sophia, and speak as follows: “We
shall not get in time to the aid of Grand Prince Dmítri Ivánovich.”
Then they flew together like eagles from the whole midnight country.
They were not eagles that flew together, but posádniks[109] that went
out with 7000 men from Nóvgorod the Great to Grand Prince Dmítri
Ivánovich and to his brother Vladímir Andréevich.
All the Russian princes came to the aid of Grand Prince Dmítri
Ivánovich, and they spoke as follows: “Lord Grand Prince! Already
do the pagan Tartars encroach upon our fields, and take away our
patrimony. They stand between the Don and Dnieper, on the river
Mechá.[110] But we, lord, will go beyond the swift river Don, will gain
glory in all the lands, will be an object of conversation for the old
men, and a memory for the young.”
Thus spoke Grand Prince Dmítri Ivánovich to his brothers, the
Russian princes: “My dear brothers, Russian princes! We are of the
same descent, from Grand Prince Iván Danílovich.[111] So far we
brothers have not been insulted either by falcon, or vulture, or white
gerfalcon, or this dog, pagan Mamáy.”
Nightingale! If you could only sing the glory of these two brothers,
Ólgerd’s sons,[112] Andréy of Pólotsk and Dmítri of Bryansk, for they
were born in Lithuania on a shield of the vanguard, swaddled under
trumpets, raised under helmets, fed at the point of the spear, and
given drink with the sharp sword. Spoke Andréy to his brother Dmítri:
“We are two brothers, sons of Ólgerd, grandchildren of Gedemín,
great-grandchildren of Skoldimér. Let us mount our swift steeds, let
us drink, O brother, with our helmets the water from the swift Don, let
us try our tempered swords.”
And Dmítri spoke to him: “Brother Andréy! We will not spare our
lives for the Russian land and Christian faith, and to avenge the
insult to Grand Prince Dmítri Ivánovich. Already, O brother, there is a
din and thunder in the famous city of Moscow. But, brother, it is not a
din or thunder: it is the noise made by the mighty army of Grand
Prince Dmítri Ivánovich and his brother Prince Vladímir Andréevich;
the brave fellows thunder with their gilded helmets and crimson
shields. Saddle, brother Andréy, your good swift steeds, for mine are
ready, having been saddled before. We will ride out, brother, into the
clear field, and will review our armies, as many brave men of
Lithuania as there are with us, but there are with us of the brave men
of Lithuania seven thousand mailed soldiers.”
Already there have arisen strong winds from the sea; they have
wafted a great cloud to the mouth of the Dnieper, against the
Russian land; bloody clouds have issued from it, and blue lightnings
flash through them. There will be a mighty din and thunder between
the Don and the Dnieper, and bodies of men will fall on the field of
Kulikóvo, and blood will flow on the river Nepryádva, for the carts
have already creaked between the Don and Dnieper, and the pagan
Tartars march against the Russian land. Grey wolves howl: they wish
at the river Mechá to invade the Russian land. Those are not grey
wolves: the infidel Tartars have come; they wish to cross the country
in war, and to conquer the Russian land. The geese have cackled
and the swans have flapped their wings,—pagan Mamáy has come
against the Russian land and has brought his generals....
What is that din and thunder so early before daybreak? Prince
Vladímir Andréevich has reviewed his army and is leading it to the
great Don. And he says to his brother, Grand Prince Dmítri
Ivánovich: “Slacken not, brother, against the pagan Tartars, for the
infidels are already in the Russian land, and are taking away our
patrimony!”...
The falcons and gerfalcons have swiftly flown across the Don, and
have swooped down on the many flocks of swans: the Russian
princes have attacked the Tartar might, and they strike with their
steel lances against the Tartar armour; the tempered swords thunder
against the Tartar helmets on the field of Kulikóvo, on the river
Nepryádva. Black is the earth under the hoofs, but they had sowed
the field with Tartar bones, and the earth was watered with their
blood, and mighty armies passed by and trampled down hills and
fields, and the rivers, springs and lakes were turbid. They uttered
mighty cries in the Russian land ... and they vanquished the Tartar
horde on the field of Kulikóvo, on the river Nepryádva.
On that field mighty clouds encountered, and in them lightnings
frequently flashed, and terrible thunders clapped: it is the Russian
brave warriors who were engaging the pagan Tartars for the great
insult, and their mighty gilded armour glistened, and the Russian
princes thundered with their tempered swords against the Tartar
helmets....
At that time neither soldiers nor shepherds called in the field near
the Don, in the land of Ryazán, but only ravens croaked for the sake
of the bodies of the dead, so that it was a terror and a pity to hear:
for the grass was watered with blood, and the trees were bent to the
ground with sorrow, and the birds sang pitiful songs. All princesses
and wives of the boyárs and generals wept for the slain. Fedósya,
the wife of Mikúla Vasílevich,[113] and Mary, the wife of Dmítri, wept
early in the morning at Moscow, standing on the city wall, and spoke
as follows: “Don, Don, you are a swift river, and have cut through
stone walls, and flow through the land of the Pólovtses! Bring back
my beloved one to me!”...
All over the Russian land there spread joy and merriment: the
Russian glory was borne through the land, but shame and
destruction came on the pagan Tartars, evil Mussulmans.... The
Grand Prince by his own bravery and with his druzhína vanquished
pagan Mamáy for the sake of the Russian land and the Christian
faith. The pagans deposited their own arms under the Russian
swords, and the trumpets were not sounded, their voices were silent.
Mamáy galloped away from his druzhína, howled like a grey wolf,
and ran away to the city of Khafest....[114]
FOOTNOTES:
TRAVEL TO INDIA